{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:58:40Z","timestamp":1763017120233,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1164,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.bbmt.2011.06.003","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T20:57:45Z","timestamp":1309035465000},"page":"220-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Limiting the Daily Total Nucleated Cell Dose of\u00a0Cryopreserved Peripheral Blood Stem Cell Products\u00a0for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on\u00a0Hematopoietic Engraftment"],"prefix":"10.1016","volume":"18","author":[{"given":"Nandita","family":"Khera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Jinneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry E.","family":"Storer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Heimfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan M.","family":"O\u2019Meara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Chauncey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Linenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2011.06.003_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.bmt.1701609","article-title":"Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases","volume":"23","author":"Alessandrino","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib2","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1080\/10428190500235611","article-title":"Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion","volume":"46","author":"Bauwens","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2011.06.003_bib3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.bmt.1702452","article-title":"Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis","volume":"25","author":"Benekli","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1423-0410.2008.01060.x","article-title":"Toxicity related to autologous peripheral blood haematopoietic progenitor cell infusion is associated with number of granulocytes in graft, gender and diagnosis of multiple myeloma","volume":"95","author":"Bojanic","year":"2008","journal-title":"Vox Sang"},{"key":"10.1016\/j.bbmt.2011.06.003_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood.V75.3.781.781","article-title":"Clinical toxicity of cryopreserved bone marrow graft infusion","volume":"75","author":"Davis","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2011.06.003_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bmt.1705830","article-title":"Recovery, viability and clinical toxicity of thawed and washed haematopoietic progenitor cells: analysis of 952 autologous peripheral blood stem cell transplantations","volume":"40","author":"Fois","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.bmt.1702443","article-title":"Neurological events associated with the infusion of cryopreserved bone marrow and\/or peripheral blood progenitor cells","volume":"25","author":"Hoyt","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/14653240701326756","article-title":"Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age","volume":"9","author":"Milone","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2011.06.003_bib9","first-page":"401","article-title":"Cardiac arrest after autologous marrow infusion","volume":"7","author":"Rapoport","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib10","first-page":"311","article-title":"Severe central nervous system toxicity associated with the infusion of cryopreserved PBSC components","volume":"1","author":"Rowley","year":"1999","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2011.06.003_bib11","first-page":"195","article-title":"Acute renal failure associated with autologous bone marrow transplantation","volume":"2","author":"Smith","year":"1987","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1537-2995.1991.31691306250.x","article-title":"Adverse reactions in patients transfused with cryopreserved marrow","volume":"31","author":"Stroncek","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2011.06.003_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bmt.1703848","article-title":"Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation","volume":"31","author":"Windrum","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib14","first-page":"4705","article-title":"Clinical toxicity of cryopreserved circulating progenitor cells infusion","volume":"18","author":"Zambelli","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bbmt.2011.06.003_bib15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s002770000186","article-title":"Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure","volume":"79","author":"Zenhausern","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2011.06.003_bib16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1537-2995.2007.01267.x","article-title":"Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product","volume":"47","author":"Calmels","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2011.06.003_bib17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/sj.bmt.1705861","article-title":"The occurrence of adverse events during the infusion of autologous peripheral blood stem cells is related to the number of granulocytes in the leukapheresis product","volume":"40","author":"Cordoba","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.transci.2006.05.019","article-title":"Clinical side effects during peripheral blood progenitor cell infusion","volume":"36","author":"Donmez","year":"2007","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bbmt.2011.06.003_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bmt.1700794","article-title":"Early\u00a0and fatal immune haemolysis after so-called \u201cminor\u201d ABO-incompatible peripheral blood stem cell allotransplantation","volume":"19","author":"Oziel-Taieb","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1537-2995.1999.39080824.x","article-title":"Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation","volume":"39","author":"Salmon","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2011.06.003_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1537-2995.2004.03230.x","article-title":"Patient care during infusion of hematopoietic progenitor cells","volume":"44","author":"Sauer-Heilborn","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2011.06.003_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1423-0410.1994.tb05034.x","article-title":"Microbiologic contamination of peripheral blood stem cell autografts","volume":"67","author":"Schwella","year":"1994","journal-title":"Vox Sang"},{"year":"2003","series-title":"Common Terminology Criteria for Adverse Events v3.0","key":"10.1016\/j.bbmt.2011.06.003_bib23"},{"key":"10.1016\/j.bbmt.2011.06.003_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1537-2995.2009.02350.x","article-title":"A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma","volume":"50","author":"Cooling","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2011.06.003_bib25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1537-2995.1999.39111200.x","article-title":"Collection of peripheral blood progenitor cells with an automated leukapheresis system","volume":"39","author":"Rowley","year":"1999","journal-title":"Transfusion"},{"issue":"Suppl","key":"10.1016\/j.bbmt.2011.06.003_bib26","first-page":"30S","article-title":"How to ensure safe and well-tolerated stem cell infusions","volume":"38","author":"Graves","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2011.06.003_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.bmt.1705298","article-title":"Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation","volume":"37","author":"Pavone","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/sj.bmt.1705708","article-title":"Difficult stem cell mobilization despite adequate CD34+ cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma","volume":"40","author":"Tomblyn","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib29","first-page":"446","article-title":"Effects of high whole blood flow rates and high peripheral WBC on CD34+ yield and cross-cellular contamination","volume":"5","author":"Burgstaler","year":"2003","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2011.06.003_bib30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.bmt.1704781","article-title":"Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?","volume":"35","author":"Gidron","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib31","doi-asserted-by":"crossref","unstructured":"Duarte RF, Shaw BE, Marin P, et\u00a0al. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant. 46:52-58.","DOI":"10.1038\/bmt.2010.54"},{"key":"10.1016\/j.bbmt.2011.06.003_bib32","doi-asserted-by":"crossref","unstructured":"Dugan MJ, Maziarz RT, Bensinger WI, et\u00a0al. Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin\u2019s lymphoma undergoing stem cell mobilization. Bone Marrow Transplant. 45:39-47.","DOI":"10.1038\/bmt.2009.119"},{"key":"10.1016\/j.bbmt.2011.06.003_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbmt.2008.11.028","article-title":"Treatment with plerixafor in non-Hodgkin\u2019s lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient","volume":"15","author":"Stiff","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2011.06.003_bib34","unstructured":"National Bone Marrow Transplant LINK resource guide. Available from: http:\/\/www.nbmtlink.org\/resources_support\/rg\/rg_costs.htm). Accessed January 27, 2011."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111002461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879111002461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:42:38Z","timestamp":1761057758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879111002461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1083879111002461"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.06.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Limiting the Daily Total Nucleated Cell Dose of\u00a0Cryopreserved Peripheral Blood Stem Cell Products\u00a0for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on\u00a0Hematopoietic Engraftment","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2011.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}